Electrokinetic potential-stabilization by bile acid-microencapsulating formulation of pancreatic β-cells cultured in high ratio poly-L-ornithine-gel hydrogel colloidal dispersion: applications in cell-biomaterials, tissue engineering and biotechnological applications

References

• Mooranian A, Negrulj R, Al-Salami H. Primary bile acid chenodeoxycholic acid-based microcapsules to examine β-cell survival and the inflammatory response. BioNanoScience. 2016;6:103–109.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Jamieson E, et al. Biological assessments of encapsulated pancreatic β-cells: their potential transplantation in diabetes. Cell Mol Bioeng. 2016;9:530–537.
   Web of Science ®Google Scholar
• Negrulj R, Mooranian A, Al-Salami H. Potentials and limitations of bile acids in type 2 diabetes mellitus: applications of microencapsulation as a novel oral delivery system. J Endocrinol Diabet Mellit. 2013;1:49–59.
   Google Scholar
• Mooranian A, Negrulj R, Arfuso F, et al. The effect of a tertiary bile acid, taurocholic acid, on the morphology and physical characteristics of microencapsulated probucol: potential applications in diabetes: a characterization study. Drug Deliv Transl Res. 2015;5:511–522.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, et al. Novel multicompartmental bile acid-based microcapsules for pancreatic beta-cell transplantation. Transplantation. 2015;99:S151–S1S2.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The incorporation of water-soluble gel matrix into bile acid-based microcapsules for the delivery of viable β-cells of the pancreas, in diabetes treatment: biocompatibility and functionality studies. Drug Deliv Transl Res. 2015;6:17–23.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. Flow vibration-doubled concentric system coupled with low ratio amine to produce bile acid-macrocapsules of beta-cells. Ther Deliv. 2016;7:171–178.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The influence of stabilized deconjugated ursodeoxycholic acid on polymer-hydrogel system of transplantable NIT-1 cells. Pharm Res. 2016;33:1182–1190.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, et al. Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic β-cells. Artif Cells Nanomed Biotechnol. 2014;44:194–200.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, et al. Advanced bile acid-based multi-compartmental microencapsulated pancreatic beta-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment. Artif Cells Nanomed Biotechnol. 2014;44:588–595.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, et al. An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations. Pharm Dev Technol. 2015;20:702–709.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. Alginate-deoxycholic acid interaction and its impact on pancreatic Β-cells and insulin secretion and potential treatment of type 1 diabetes. J Pharm Innovat. 2016;11:156–161.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The effects of ionic gelation: vibrational jet flow technique in fabrication of microcapsules incorporating beta-cell: applications in type-1 diabetes. Curr Diabetes Rev. 2015;13:91–96.
   Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The impact of allylamine-bile acid combinations on cell delivery microcapsules in diabetes. J Microencapsul. 2016;33:569–574.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. Viability and topographical analysis of microencapsulated β-cells exposed to a biotransformed tertiary bile acid: an ex vivo study. Int J Nano Biomater. 2016;6:74.
   Google Scholar
• Mooranian A, Negrulj R, Al-Salami H, et al. Designing anti-diabetic beta-cells microcapsules using polystyrenic sulfonate, polyallylamine, and a tertiary bile acid: Morphology, bioenergetics, and cytokine analysis. Biotechnol Prog. 2016;32:501–509.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, et al. Characterization of a novel bile acid-based delivery platform for microencapsulated pancreatic beta-cells. Artif Cells Nanomed Biotechnol. 2016;44:194–200.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Arfuso F, et al. Multicompartmental, multilayered probucol microcapsules for diabetes mellitus: formulation characterization and effects on production of insulin and inflammation in a pancreatic beta-cell line. Artif Cells Nanomed Biotechnol. 2015;44:1642–1653.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Morahan G, et al. Designing anti-diabetic beta-cells microcapsules using polystyrenic sulfonate, polyallylamine and a tertiary bile acid: Morphology, bioenergetics and cytokine analysis. Biotechnol Prog. 2016;32:501–509.
   PubMed Web of Science ®Google Scholar
• De Vos P, De Haan BJ, Kamps JA, et al. Zeta-potentials of alginate-PLL capsules: a predictive measure for biocompatibility? J Biomed Mater Res. 2007;80:813–819.
   Google Scholar
• Rokstad AM, Lacik I, De Vos P, et al. Advances in biocompatibility and physico-chemical characterization of microspheres for cell encapsulation. Adv Drug Deliv Rev. 2013;67–68:111–130.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Salami H. The effects of ionic gelation-vibrational jet flow technique in fabrication of microcapsules incorporating β-cell: applications in diabetes. Curr Diabetes Rev. 2017;13:91–96.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Takechi R, et al. New biotechnological microencapsulating methodology utilizing individualized gradient-screened jet laminar flow techniques for pancreatic beta-cell delivery: bile acids support cell energy-generating mechanisms. Mol Pharm. 2017. [Epub ahead of print]. doi: 10.1021/acs.molpharmaceut
   PubMedGoogle Scholar
• Mooranian A, Tackechi R, Jamieson E, et al. The effect of molecular weights of microencapsulating polymers on viability of mouse-cloned pancreatic beta-cells: biomaterials, osmotic forces and potential applications in diabetes treatment. Pharm Dev Technol. 2017. [Epub ahead of print]. doi: 10.1080/10837450.2017.1321664.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Tackechi R, Jamieson E, et al. Innovative microcapsules for pancreatic beta-cells harvested from mature double-transgenic mice: cell imaging, viability, induced glucose-stimulated insulin measurements and proinflammatory cytokines analysis. Pharm Res. 2017;34:1217–1223.
   PubMed Web of Science ®Google Scholar
• Thomas HE, Angstetra E, Fernandes RV, et al. Perturbations in nuclear factor-kappaB or c-Jun N-terminal kinase pathways in pancreatic beta cells confer susceptibility to cytokine-induced cell death. Immunol Cell Biol. 2006;84:20–27.
   PubMed Web of Science ®Google Scholar
• Hamaguchi K, Gaskins HR, Leiter EH. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes. 1991;40:842–849.
   PubMed Web of Science ®Google Scholar
• Negrulj R, Mooranian A, Chen-Tan N, et al. Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetes. Artif Cells Nanomed Biotechnol. 2015;44:1290–1297.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, et al. Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study. Drug Design Develop Ther. 2014;8:1003.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, et al. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol. Drug Des Develop Ther. 2014;8:1221–1230.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Chen-Tan N, et al. An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancer. Drug Des Devel Ther. 2014;8:1673–1683.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mathavan S, et al. Stability and release kinetics of an advanced gliclazide-cholic acid formulation: the use of artificial-cell microencapsulation in slow release targeted oral delivery of antidiabetics. J Pharm Innovat. 2014;9:150–157.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Sallami HS, et al. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment. J Microencapsul. 2014;32:151–156.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Al-Sallami HS, et al. Probucol release from novel multicompartmental microcapsules for the oral targeted delivery in type 2 diabetes. AAPS PharmSciTech. 2014;16:45–52.
   PubMed Web of Science ®Google Scholar
• Mooranian A, Negrulj R, Mikov M, et al. Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro study. J Microencapsul. 2015;32:589–597.
   PubMed Web of Science ®Google Scholar
• Takka S, Cali AG. Bile salt-reinforced alginate-chitosan beads. Pharm Dev Technol. 2012;17:23–29.
   PubMed Web of Science ®Google Scholar
• De Vos P, De Haan BJ, Wolters GH, et al. Improved biocompatibility but limited graft survival after purification of alginate for microencapsulation of pancreatic islets. Diabetologia. 1997;40:262–270.
   PubMed Web of Science ®Google Scholar
• De Vos P, Hamel A, Tatarkiewicz K. Considerations for successful transplantation of encapsulated pancreatic islets. Diabetologia. 2002;45:159–173.
   PubMed Web of Science ®Google Scholar
• Kullmann F, Gross V, Ruschoff J, et al. Effect of ursodeoxycholic acid on the inflammatory activity of indomethacin-induced intestinal inflammation in rats. Z Gastroenterol. 1997;35:171–178.
   PubMed Web of Science ®Google Scholar
• Martinez-Moya P, Romero-Calvo I, Requena P, et al. Dose-dependent antiinflammatory effect of ursodeoxycholic acid in experimental colitis. Int Immunopharmacol. 2013;15:372–380.
   PubMed Web of Science ®Google Scholar
• De Vos P, Lazarjani HA, Poncelet D, et al. Polymers in cell encapsulation from an enveloped cell perspective. Adv Drug Deliv Rev. 2013;67–68:15–34.
   PubMed Web of Science ®Google Scholar
• Bhatia SR, Khattak SF, Roberts SC. Polyelectrolytes for cell encapsulation. Curr Opin Colloid Interface Sci. 2005;10:45–51.
   Web of Science ®Google Scholar